The Pennant Group Inc. Common Stock (PNTG)

FairStock Score: 52/100 — MIXED

Key Financials

Strengths

• Generates $7 million in annual free cash flow (0.7% yield on market cap)
• Revenue growth of 53.2% demonstrates strong top-line momentum

Concerns

• Trades significantly above Graham Number ($13) with negative 123% margin of safety—limited downside protection
• Altman Z-Score of 1.6 places it in the financial distress zone—elevated bankruptcy risk

AI Analysis

The Pennant Group Inc. Common Stock is a micro-cap healthcare company valued at $1.0 billion. The business generates $948 million in annual revenue with a 0.9% net margin and $7 million in free cash flow. From a quality standpoint, The shows distressed Altman Z-Score of 1.6 warrants caution and modest 10% ROE. On valuation, the stock is trading at a premium 35.9x earnings, with trades far above its Graham Number ($13) with no margin of safety. Growth dynamics show revenue growing at 53.2% and profit growth of 50.0%. Our composite FairStock Score of 52/100 reflects mixed fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

The's 53% revenue growth trajectory could accelerate as it captures additional market share in the healthcare sector. With $7 million in annual free cash flow (0.7% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

At 36x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer